Research
Title : | Human monoclonal antibodies against SARS-CoV-2 |
Area of research : | COVID-19 Research, Life Sciences & Biotechnology |
Focus area : | SARS-CoV-2 virus |
Principal Investigator : | Dr Anmol Chandele, Group Leader, Emory Vaccine Program-The International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi |
Timeline Start Year : | 2020 |
Contact info : | chandeleanmol@gmail.com |
Details
Executive Summary : | This project aims to generate and analyse human monoclonal antibodies from single cell sorted memory B cells derived from COVID-19 recovered individuals in India for their neutralising activity on SARS-CoV-2. |
Outcome/Output: | This work showed that nearly half of the COVID-19 recovered individuals developed neutralising antibodies and these individuals can be identified by simple to use SARS-CoV-2 RBD ELISA’s. |
Organizations involved
Implementing Agency : | The International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi Funding Agency :Department of Biotechnology (DBT) Govt. of India | |